SomnoMed (ASX:SOM) Other Net Income (Loss) : A$0.00 Mil (TTM As of Jun. 2024)

View and export this data going back to 2004. Start your Free Trial

What is SomnoMed Other Net Income (Loss)?

SomnoMed's Other Net Income (Loss) for the six months ended in Jun. 2024 was A$0.00 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Jun. 2024 was A$0.00 Mil.

SomnoMed's quarterly Other Net Income (Loss) increased from Jun. 2023 (A$-0.09 Mil) to Dec. 2023 (A$0.00 Mil) but then stayed the same from Dec. 2023 (A$0.00 Mil) to Jun. 2024 (A$0.00 Mil).

SomnoMed's annual Other Net Income (Loss) declined from Jun. 2022 (A$-0.01 Mil) to Jun. 2023 (A$-0.13 Mil) but then increased from Jun. 2023 (A$-0.13 Mil) to Jun. 2024 (A$0.00 Mil).

SomnoMed Other Net Income (Loss) Historical Data

The historical data trend for SomnoMed's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SomnoMed Other Net Income (Loss) Chart

SomnoMed Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Other Net Income (Loss)

Get a 7-Day Free Trial

-0.68

-0.11

-0.01

-0.13

SomnoMed Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Other Net Income (Loss)	Get a 7-Day Free Trial															-0.02	-0.04	-0.09	-	-

SomnoMed Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.00 Mil.

SomnoMed Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of SomnoMed's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

SomnoMed Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » SomnoMed Ltd (ASX:SOM) » Definitions » Other Net Income (Loss)

Comparable Companies

Traded in Other Exchanges

SOMNF:USA RJV:Germany

Address

20 Clarke Street, Level 3, Crows Nest, Sydney, NSW, AUS, 2065

Website

https://www.somnomed.com/au

SomnoMed Ltd produces and sells oral treatment of sleep-related disorder devices. It manufactures and designs premium oral appliances for the treatment of sleep-disordered breathing relieving conditions. Its products include SomnoDent, Som Tabs, Som Morning Repositioner and others. Its geographical segments include North America, Europe, and Asia-Pacific. Business operations consist of the production and sale of products treating sleep-disordered breathing, which is the only reportable segment. Substantial revenue is realized from the European region.

SomnoMed Headlines

No Headlines